Ibrahim (Abe) Gökçe Yayla, Ph.D., Chief Executive Officer
Inanç Ortaç, Ph.D., Chief Technology Officer
Sadik Esener, Ph.D., Chairman of the Scientific Advisory Board
Bradley Messmer, Ph.D., Vice President R&D
Started multiple technology companies with successful exits, including InnoComm Wireless ($130M sale to National Semiconductor, 2000). Abe has multiple years of engineering management experience. He worked or performed consulting services for many major semiconductor companies including Intel, Fairchild, National Semiconductor, Cypress Semiconductor, Conexant, AMCC, PCSI, Trident, ABB Hafo, Nanogen, Nanotronics and Opti. Dr. Yayla is the author of multiple papers, holds 6 issued U.S. Patents, and contributed to more than 20 designs that went to production. Dr.Yayla received a Ph.D degree from UC San Diego in Electrical Engineering and Applied Physics.
Dr. Ortaç has invented and developed the SHELS technology during his doctoral studies at Moores Cancer Center, University of California, San Diego. He won the grand prize in the national Collegiate Inventors Competition in 2012 with the SHELS technology. The SHELS technology also won the first prize in UC San Diego Entrepreneur Challenge in 2013. Previously, Inanc placed second in the UC San Diego Entrepreneur Challenge with a business plan for a different invention, a medical device for rapid on-site detection of hospital-acquired infections. He co-founded DevaCell Inc. around the SHELS technology and currently serves as the company’s chief technology officer. Dr. Ortaç is the author of several papers and holds 5 issued and pending patents.
Professor of Photonics and Nanotechnology. After leading UCSD’s OptoElectronic Computing Group for more than a decade, Dr. Esener became the director and Principal Investigator of the NanoTumor Center for Cancer Nanotechnology of Excellence funded by NCI. He has authored more than 100 journal publications and 250 conference abstracts. Esener co-founded San Diego-based Nanogen, Optical Micro-Machines, Parallel Solutions, Genoptix, and Call/Recall and Ziva.